October was a busy month for biodrook™: our solutions are increasingly used in clinical practice, and our team took an active part in key professional events across the industry.

Clinical practice Six successful surgeries were performed in October using biodrook™ solutions. Each case confirms the reliability of our implants and the growing trust of surgeons in Ukrainian-made products.

General sponsorship in Poltava biodrook™ served as general sponsor of a scientific and practical conference in Poltava, supporting continuing education for medical professionals in the region.

Trauma Congress Ukraine 2026 The biodrook™ team joined discussions on reconstructive surgery and complex clinical cases, exchanging experience with leading specialists in the field.

LOTOS 2026 On October 16, we took part in the annual Lviv October Trauma Ortho Symposium in Lviv.

Guests at our facility We welcomed doctors and specialists to our manufacturing facility, showing our production processes and quality standards and discussing opportunities for further collaboration.

We continue working to ensure that doctors have reliable tools and patients can return to movement and a full life💙

biodrook™ at the Trauma Ukraine 2026 Congress

On October 15–16, 2026, the Trauma Ukraine 2026 Congress took place in Kyiv, Ukraine, organized by the All-Ukrainian Association of Injury Surgery and Rehabilitation (ASIR). The event brought together professionals in injury surgery, traumatology, and rehabilitation to discuss current approaches to complex trauma treatment, reconstructive procedures, and patient recovery. The biodrook™ team attended the congress to engage with the medical community and take part in the professional exchange of knowledge and experience.

Complex Trauma and Personalized Solutions

Treating complex injuries and reconstructing bone defects requires careful consideration of individual clinical circumstances. Patient anatomy, the nature of the injury, and the specific objectives of surgery all play a role in treatment planning. At biodrook™, these challenges are closely connected to our work on patient-specific implants and the development of advanced biomaterials. Key areas relevant to our work include:
  • Bone defect reconstruction and individualized treatment planning.
  • 3D printing in surgery and its potential for patient-specific implant design.
  • Bioresorbable materials as an area of development for technologies intended to support bone healing.
 

biodrook™ Medical Technologies

biodrook™ develops patient-specific bioresorbable implants made from a composite of polylactic acid (PLA) and hydroxyapatite. Our work combines personalized design and materials science to develop solutions for patients with bone defects. Attending the Trauma Ukraine 2026 Congress gave our team an opportunity to exchange perspectives with medical professionals and gain further insight into the challenges faced by specialists in traumatology and reconstructive surgery. We thank ASIR, the speakers, and all participants for the professional dialogue and their contribution to the medical community.

biodrook™ Supports the All-Ukrainian Scientific and Practical Conference with International Participation in Poltava

On October 8–9, 2026, Poltava State Medical University hosted an All-Ukrainian Scientific and Practical Conference with International Participation, bringing together medical professionals from Ukraine, the United States, Germany, Azerbaijan, Uzbekistan, and Georgia. One of the key topics was the application of patient-specific implants and 3D printing technologies in reconstructive surgery.

Patient-Specific Implants: Technology and Clinical Experience

The scientific program featured presentations exploring modern approaches to bone defect reconstruction using customized implants. Denys Chernohorskyi presented the potential of 3D-printed hydroxyapatite and polylactide implants in facial reconstructive surgery, highlighting initial clinical outcomes. Yevhenii Shumynskyi shared his clinical experience with ResorBone™ patient-specific implants, developed and manufactured by biodrook™. These presentations contributed to a professional discussion on the role of personalized medical devices in reconstructive surgery and their integration into clinical practice.

biodrook™ as General Sponsor

biodrook™ proudly served as the general sponsor of the conference, supporting the exchange of clinical experience, professional collaboration, and the advancement of innovative medical approaches. For biodrook™, participating in events like this is an important part of engaging with the medical community. Close collaboration with practicing surgeons helps us continuously improve patient-specific solutions based on real clinical needs. We sincerely thank Denys Chernohorskyi and Yevhenii Shumynskyi for their insightful presentations and contributions to the clinical discussion. We also extend our appreciation to Poltava State Medical University, the organizers, and all participants for creating a platform for meaningful professional exchange. biodrook™ — advancing personalized medical solutions together with healthcare professionals.

August was a month of national dialogue, growing clinical education, and confirmed quality standards for biodrook. Our team took part in key national events, continued expanding our clinical education library, joined a specialised medical conference, and confirmed compliance with an international quality standard.

We remain committed to advancing regenerative medicine, supporting medical education, and strengthening trust with our partners and physicians.

Forbes University 2026

Our Executive Director, Kateryna Osetrova, took part in Forbes University 2026, meeting new contacts and exploring opportunities for joint R&D projects in medtech.

Expanding Our Clinical Education Library

Our clinical education library continued to expand in August with the filming of new surgical cases for surgeons working with our solutions.

UNIT.City & the NV Leadership Study

UNIT.City hosted the first public presentation of NV’s large-scale study, “Top Managers Who Hold the Country,” followed by an award ceremony recognising the 16 best CEOs in Ukraine.

ERAS: Enhanced Recovery After Surgery Conference

The biodrook team joined a specialised medical conference dedicated to accelerated patient recovery after surgery (ERAS: Enhanced Recovery After Surgery).

ISO 13485 Compliance Confirmed

biodrook successfully passed its surveillance audit, confirming compliance with ISO 13485, which validates the quality, traceability, and reliability of our processes.

Ukraine’s State Flag Day & Independence Day

On 23 and 24 August, Ukraine marked State Flag Day and the 35th anniversary of its Independence 💙💛

Summary

August reaffirmed that the growth of regenerative medicine goes hand in hand with leadership dialogue, professional recognition, and continuous quality improvement.

The biodrook team remains focused on advancing innovative biomaterials, supporting medical education, and strengthening partner trust — so Ukrainian doctors have access to world-class solutions.

Closing block

CONTACT US: info@biodrook.com

Start building the future of accessible biotechnology with biodrook today!

Australian patient Reuben Lichter faced the possibility of losing his leg above the knee because of a severe bone infection. Instead, he agreed to undergo a procedure that had never before been performed on this scale, and today he is able to walk independently.

Based on reporting by ABC News Australia.

A disease that destroyed the bone

In 2017, Reuben Lichter, who had been planning a career in aviation, developed osteomyelitis, a severe infection and inflammation of bone.

The disease destroyed approximately 36 centimeters of his right tibia. In many cases involving bone loss of this magnitude, above-the-knee amputation may be considered.

Doctors offered Reuben a choice: amputation or participation in an experimental treatment with no guarantee of success.

He chose the second option, hoping to preserve his leg for himself and his family, including his young son.

Bone reconstruction with 3D printing

A research team from Queensland University of Technology created a digital model of the bone defect using the patient’s CT scans.

They then designed a patient-specific porous scaffold intended to guide the growth of new bone tissue. The scaffold itself was 3D printed in Singapore and subsequently implanted during a series of five operations performed by a plastic surgeon at Princess Alexandra Hospital.

The scaffold was surrounded by the patient’s own tissue and blood vessels harvested from both legs to provide the blood supply required for bone regeneration.

Doctors described the procedure as the first of its kind in the world on this scale.

Two years later: walking independently

The road to recovery was long and difficult, and Reuben acknowledged that there were times when he questioned his decision.

However, two years after the procedure, Reuben Lichter was able to walk without assistance for the first time since his treatment began.

Doctors and researchers described the milestone as an important step forward for the field of bone regeneration.

This case demonstrates how 3D-printing technologies and resorbable materials may open new possibilities for limb reconstruction in patients with severe infections or traumatic bone loss, including situations in which amputation might otherwise be considered.

Source: ABC News Australia. 3D-printed tibia patient walking unaided, two years on from surgery.

Brody Ellis survived a severe motorcycle accident in Vietnam and lost part of his skull. Today, his own bone is growing back, supported by a 3D-printed implant used in this way for the skull for the first time in the world.

Based on reporting by ABC News Australia, written by Stuart Layt and published on June 2, 2020.

The accident that changed everything

In 2018, Brody Ellis was involved in a severe motorcycle accident in Vietnam. He sustained serious head injuries as well as extensive trauma to his left leg, which later had to be amputated.

Because of the damage to his skull, surgeons had to remove sections of bone from both sides of his head. Later that year, Brody received plastic 3D-printed implants to close the resulting defects. However, one of the implants subsequently became infected.

When a conventional implant is not enough

Dr. Michael Wagels, Deputy Director of Plastic and Reconstructive Surgery at Princess Alexandra Hospital, explained that the staphylococcal infection posed a serious risk. Because the plastic implant had no blood supply of its own, the body was unable to effectively fight the infection around it.

The implant had to be removed.

Rather than replacing it with another conventional plastic implant, the surgeon proposed a different approach: using a newer type of implant designed to support the regeneration of Brody’s own bone across the damaged area.

A scaffold that disappears as bone grows

According to Dr. Wagels, he and his colleagues had already been experimenting with 3D-printed implants that act as temporary scaffolds. They provide a structure for bone growth and then gradually dissolve as newly formed bone tissue occupies the space.

The team had previously used a similar technology to reconstruct bone in a patient’s leg, but this was the first time in the world that the approach had been used for the skull.

The operation lasted 11 hours.

First results after just six weeks

Follow-up CT scans showed that new bone tissue had begun forming along both the outer and inner surfaces of the implant just six weeks after surgery. No complications were reported at that stage.

People with substantial skull defects may need to wear protective helmets in public and can experience severe headaches associated with pressure changes affecting the brain. With the new implant in place, Brody was able to avoid this problem and focus on his rehabilitation.

Brody himself admitted that the idea of “growing bone back in his head” initially sounded almost unbelievable, but the result exceeded his expectations.

His surgeon, meanwhile, emphasized that much of the progress was also due to Brody’s own determination and persistence throughout his recovery.

July was another productive month for biodrook, bringing together clinical education, strategic partnerships, industry events, and innovation. Throughout the month, our team strengthened international relationships, expanded educational initiatives for healthcare professionals, welcomed distinguished guests to our manufacturing facility, and actively contributed to discussions shaping the future of healthcare in Ukraine. As a company committed to regenerative medicine, biomaterials, and medical innovation, we continue building partnerships that support better clinical outcomes and professional education.

American Chamber of Commerce Networking Event

The biodrook team participated in a networking event organized by the American Chamber of Commerce in Ukraine, strengthening relationships with the international business community. During the event, we met with representatives of the U.S. Embassy in Ukraine, innovative Ukrainian companies, and potential partners. These conversations opened new opportunities for future collaboration in healthcare innovation and medical technologies.

Celebrating the 250th Anniversary of the Independence of the United States

In July, biodrook had the honor of attending the official celebration marking the 250th anniversary of the Independence of the United States in Kyiv. The event brought together representatives of the diplomatic community, government institutions, international organizations, and businesses. It provided another valuable opportunity to strengthen existing partnerships and establish new professional connections.

Expanding Clinical Education Content

Supporting healthcare professionals through education remains one of biodrook’s strategic priorities. During July, our team successfully filmed two additional clinical surgical cases, further expanding our educational library with real-world procedures. These materials help surgeons gain practical experience, learn best practices for biomaterial application, and enhance their clinical expertise.

HealthTech Roundtable at SET University

Our CEO participated in the roundtable discussion “From Fragmentation to System: Building HealthTech in Ukraine Together”, hosted by SET University. The event gathered representatives of the Ministry of Health of Ukraine, healthcare providers, HealthTech startups, academic institutions, and international partners to discuss the future of Ukraine’s digital healthcare ecosystem. The discussion reinforced our belief that Ukraine possesses exceptional engineering talent, strong clinical expertise, and significant innovation potential. Continued collaboration between government, academia, and industry will be essential to transforming these strengths into meaningful healthcare solutions.

VRNOW × biodrook Collaboration

During July, biodrook partnered with VRNOW on a joint Instagram collaboration highlighting the growing role of virtual reality and immersive technologies in modern medical education. This partnership reflects our shared vision of making professional knowledge more accessible through innovative educational formats and digital communication.

Manufacturing Facility Visits

Throughout the month, biodrook welcomed several distinguished guests to our manufacturing facility, providing an opportunity to demonstrate our production processes, quality management system, and ongoing innovations in regenerative medicine. Among our visitors were Ernest (E.J.) Herold, former NATO Deputy Assistant Secretary General for Defence Investment and retired U.S. Army Colonel, and Professor Stanislav Bondarenko, one of Ukraine’s leading orthopedic trauma surgeons. These meetings created valuable opportunities to exchange expertise, discuss current clinical challenges, and explore future collaboration in healthcare innovation.

Med Forum Odesa

The biodrook team also participated in Med Forum Odesa, a multidisciplinary educational event bringing together physicians, healthcare professionals, interns, and medical students from across Ukraine. The forum featured expert discussions covering blood donation, vaccination, diagnostics, evidence-based medicine, patient communication, and modern approaches to healthcare delivery. Particularly valuable for our team were the sessions dedicated to communication with veterans and patients affected by blast injuries. These discussions highlighted the importance of combining advanced medical technologies with compassionate, patient-centered care. Events like Med Forum strengthen collaboration across medical specialties and contribute to building a more integrated and resilient healthcare system.

Looking Ahead

Every partnership, educational initiative, and professional dialogue strengthens biodrook’s mission to advance regenerative medicine through innovation, clinical education, and international collaboration. We remain committed to developing high-quality biomaterials, supporting healthcare professionals, and delivering innovative medical technologies that improve patient care in Ukraine and beyond.

On July 28, 2026, Med Forum Odesa took place at the Biopharma Plasma donation center in Odesa, Ukraine. The professional event brought together physicians, healthcare professionals, medical interns, and students from a wide range of medical specialties.

Organized by Biopharma Plasma Odesa in partnership with the MEDEA clinic, the forum created a platform for sharing knowledge, practical experience, and modern approaches to patient care.

Participants toured the plasma donation center, connected with colleagues, and joined discussions on important topics in modern healthcare, including:

• the role of blood component donation in saving lives;

• current perspectives on human papillomavirus, prevention, and vaccination;

• the specific aspects of working with isoimmune donors;

• communication with veterans and patients who have experienced blast-related injuries;

• evidence-based treatment decisions and the “just in case” approach;

• vaccination schedules and the importance of immunization;

• new approaches to disease diagnosis;

• the criteria modern patients use when choosing a physician and the factors that build trust.

For the biodrook team, the discussions related to communication with veterans and people affected by blast-related injuries were especially valuable. Supporting these patients requires not only modern medical solutions but also sensitive, consistent, and responsible guidance throughout every stage of treatment and recovery.

Professional events such as Med Forum Odesa help representatives of different healthcare fields better understand one another’s experience, identify new opportunities for collaboration, and contribute to a more patient-centered healthcare system in Ukraine.

Med Forum Odesa in Odesa, Ukraine

We sincerely thank Donation Center Director Kateryna Yefremova, the Biopharma Plasma Odesa team, and the MEDEA clinic for organizing the event, preparing a meaningful program, encouraging open professional dialogue, and creating a space for valuable communication within the medical community.

We believe that the advancement of healthcare begins with knowledge sharing, interdisciplinary collaboration, and a shared commitment to creating better solutions for patients.

CONTACT US

info@biodrook.com

Start building the future of accessible biotechnology with biodrook today!